Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase

NCT01257399 is registered in ClinicalTrials.gov with Tillotts Pharma AG as lead sponsor.

NCT NCT01257399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01257399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase
Lead sponsor
Tillotts Pharma AG
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2010
Completion date
March 31, 2013
Enrollment
251 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis in remission